{"id":{"repo_id":"marshall","oai_identifier":"oai:mds.marshall.edu:etd-2774"},"canonical_url":"https://search.ndltd.org/etd/marshall/oai:mds.marshall.edu:etd-2774","repository":{"repo_id":"marshall","name":"Marshall University","base_url":"https://mds.marshall.edu/do/oai/"},"display":{"title":"Inhibition of the mTOR signaling pathway in clear cell renal cell carcinoma cells","abstract":"The mammalian target of Rapamycin (mTOR) is a Serine/threonine kinase that is found in two large protein complexes that are known as mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). Torin 1 is an ATP-competitive inhibitor of mTOR that inhibits mTOR activity in both mTORC1 and mTORC2. In this study, we hypothesized that dual inhibition of mTORC1 and mTORC2 with Torin 1 promotes the apoptosis of clear cell renal cell carcinoma cells. The human clear cell renal cell cancer line, 786-0, was treated with Torin 1, and markers of apoptosis, including PARP, Caspase 3, and Caspase 9, and their cleaved subunit proteins were studied using the Western Blot technique. To further investigate the role of mTORC2, short interfering RNA (siRNA) experiments in 786-0 cells were performed to selectively reduce the expression of Rictor, the defining subunit of mTORC2. Our findings demonstrate increased expression of Caspase 3 and Cleaved PARP in 786-0 cells treated with Torin1 which confirms activation of apoptosis. No human or animal was involved in this study.","abstract_html":"The mammalian target of Rapamycin (mTOR) is a Serine/threonine kinase that is found in two large protein complexes that are known as mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). Torin 1 is an ATP-competitive inhibitor of mTOR that inhibits mTOR activity in both mTORC1 and mTORC2. In this study, we hypothesized that dual inhibition of mTORC1 and mTORC2 with Torin 1 promotes the apoptosis of clear cell renal cell carcinoma cells. The human clear cell renal cell cancer line, 786-0, was treated with Torin 1, and markers of apoptosis, including PARP, Caspase 3, and Caspase 9, and their cleaved subunit proteins were studied using the Western Blot technique. To further investigate the role of mTORC2, short interfering RNA (siRNA) experiments in 786-0 cells were performed to selectively reduce the expression of Rictor, the defining subunit of mTORC2. Our findings demonstrate increased expression of Caspase 3 and Cleaved PARP in 786-0 cells treated with Torin1 which confirms activation of apoptosis. No human or animal was involved in this study.","abstract_has_math":false,"creators":["Farimand, Samaneh"],"institution":null,"degree_name":"Biomedical Sciences","degree_level":"Thesis","degree_discipline":"Joan C. Edwards School of Medicine","degree_department":null,"school":null,"contributors":["Dr. Travis Salisbury, Committee Chairperson","Dr. Richard Egleton","Dr. Larry Grover"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":null,"date_issued":"","date_published":null,"updated_at":"2026-11-21T19:58:01Z","subjects":[],"languages":[],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"https://mds.marshall.edu/etd/1769","outbound_label":"Repository record","outbound_source":"dc:identifier","record_url":"https://mds.marshall.edu/etd/1769","record_label":"Repository record","record_kind":"record","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://mds.marshall.edu/do/oai/?verb=GetRecord&metadataPrefix=oai_etdms&identifier=oai%3Amds.marshall.edu%3Aetd-2774","prefix":"oai_etdms"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Dr. Travis Salisbury, Committee Chairperson","Dr. Richard Egleton","Dr. Larry Grover"]},{"key":"dc:creator","label":"Author","values":["Farimand, Samaneh"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.available","label":"Dc Date Available","values":["2025-05-01T07:00:00Z"]},{"key":"dc:date.created","label":"Dc Date Created","values":["2023-01-01T08:00:00Z"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Joan C. Edwards School of Medicine"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Thesis"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Biomedical Sciences"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://mds.marshall.edu/etd/1769"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["The mammalian target of Rapamycin (mTOR) is a Serine/threonine kinase that is found in two large protein complexes that are known as mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). Torin 1 is an ATP-competitive inhibitor of mTOR that inhibits mTOR activity in both mTORC1 and mTORC2. In this study, we hypothesized that dual inhibition of mTORC1 and mTORC2 with Torin 1 promotes the apoptosis of clear cell renal cell carcinoma cells. The human clear cell renal cell cancer line, 786-0, was treated with Torin 1, and markers of apoptosis, including PARP, Caspase 3, and Caspase 9, and their cleaved subunit proteins were studied using the Western Blot technique. To further investigate the role of mTORC2, short interfering RNA (siRNA) experiments in 786-0 cells were performed to selectively reduce the expression of Rictor, the defining subunit of mTORC2. Our findings demonstrate increased expression of Caspase 3 and Cleaved PARP in 786-0 cells treated with Torin1 which confirms activation of apoptosis. No human or animal was involved in this study."]},{"key":"dc:title","label":"Title","values":["Inhibition of the mTOR signaling pathway in clear cell renal cell carcinoma cells"]}]}],"canonical_facts":{"dc:contributor":["Dr. Travis Salisbury, Committee Chairperson","Dr. Richard Egleton","Dr. Larry Grover"],"dc:creator":["Farimand, Samaneh"],"dc:date.available":["2025-05-01T07:00:00Z"],"dc:date.created":["2023-01-01T08:00:00Z"],"dc:description.abstract":["The mammalian target of Rapamycin (mTOR) is a Serine/threonine kinase that is found in two large protein complexes that are known as mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). Torin 1 is an ATP-competitive inhibitor of mTOR that inhibits mTOR activity in both mTORC1 and mTORC2. In this study, we hypothesized that dual inhibition of mTORC1 and mTORC2 with Torin 1 promotes the apoptosis of clear cell renal cell carcinoma cells. The human clear cell renal cell cancer line, 786-0, was treated with Torin 1, and markers of apoptosis, including PARP, Caspase 3, and Caspase 9, and their cleaved subunit proteins were studied using the Western Blot technique. To further investigate the role of mTORC2, short interfering RNA (siRNA) experiments in 786-0 cells were performed to selectively reduce the expression of Rictor, the defining subunit of mTORC2. Our findings demonstrate increased expression of Caspase 3 and Cleaved PARP in 786-0 cells treated with Torin1 which confirms activation of apoptosis. No human or animal was involved in this study."],"dc:identifier":["https://mds.marshall.edu/etd/1769"],"dc:title":["Inhibition of the mTOR signaling pathway in clear cell renal cell carcinoma cells"],"thesis:degree_discipline":["Joan C. Edwards School of Medicine"],"thesis:degree_level":["Thesis"],"thesis:degree_name":["Biomedical Sciences"]},"updated_at":"2026-11-21T19:58:01Z"}